For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250625:nRSY2437Oa&default-theme=true
RNS Number : 2437O Halma PLC 25 June 2025
Halma plc
Annual General Meeting 2025 (AGM) - Revised Form of Proxy
Following the publication and posting of the Notice of AGM of the Company to
be held on 24 July 2025, together with a Form of Proxy, it has come to the
Company's attention that the Form of Proxy contains a minor typographical
error in relation to resolution 5. For the avoidance of doubt, the resolutions
set out in the 2025 Notice of AGM are correct and the typographical error in
the Form of Proxy does not affect the validity of the resolutions.
A Form of Proxy which has been submitted, or which is submitted prior to the
proxy voting deadline of 12.30pm on 22 July 2025, will be treated as valid,
notwithstanding the typographical error. As such, shareholders who have
already returned their Form of Proxy do not need to take any action. A revised
Form of Proxy is available on the Company's website at
https://www.halma.com/investors/shareholder-information/agm-information
(https://www.halma.com/investors/shareholder-information/agm-information) .
Shareholders who have not yet returned a Form of Proxy, or who wish to amend
their original submission, may use the revised Form of Proxy, if
preferred.
The revised Form of Proxy has also been submitted to the National Storage
Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
For further information, please contact:
Mark Jenkins
Company Secretary, Halma plc
Tel: +44 (0)1494 721111
NOTE TO EDITORS
Halma is a global group of life-saving technology companies, focused on
growing a safer, cleaner, healthier future for everyone, every day. Its
purpose defines the three market areas where it operates:
· Safety Protecting people, assets and infrastructure in commercial, industrial and
public spaces. Reducing safety risks in hazardous situations, increasing
efficiency and helping to create a more sustainable future.
· Environmental & Analysis Monitoring and protecting the environment, and ensuring the quality and
availability of life‑critical resources. Creating solutions used in
materials analysis and optoelectronic applications.
· Healthcare Improving the care delivered by healthcare providers, and enhancing the
quality of patients' lives, through contributing to the discovery and
development of new cures, the diagnosis and treatment of patient conditions,
and data analysis.
Halma employs over 9,000 people in more than 20 countries, with major
operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is
listed on the London Stock Exchange (LON: HLMA) and is a constituent of the
FTSE 100 index.
Halma has been named one of Britain's Most Admired Companies for the past six
years.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGZGZVVDVGKZM